Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer

References

• Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst. 2018;110(4):1–9. doi:10.1093/jnci/djx214.
   Google Scholar
• NCCN. NCCN Guidelines for Uterine Neoplasms Version 1.2022. NCCN Guidelines www.nccn.org. (2022).
   Google Scholar
• Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12(5):469–476. doi:10.1016/S1470-2045(11)70070-5.
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol. 2013;20(2):353–354. doi:10.1245/s10434-012-2685-8.
   PubMed Web of Science ®Google Scholar
• Cormier B, Rozenholc AT, Gotlieb W, Communities of Practice (CoP) Group of Society of Gynecologic Oncology of Canada (GOC), et al. Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol. 2015;138(2):478–485. doi:10.1016/j.ygyno.2015.05.039.
   PubMed Web of Science ®Google Scholar
• Franchi M, Ghezzi F, Riva C, et al. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78(4):232–237. discussion 237240, doi:10.1002/jso.1158.
   PubMed Web of Science ®Google Scholar
• Lipetskaia L, Sharma S, Johnson MS, Ostergard DR, Francis S. Urinary incontinence and quality of life in endometrial cancer patients after robotic-assisted laparoscopic hysterectomy with lymph node dissection. J Obstet Gynaecol. 2019;39(7):986–990. doi:10.1080/01443615.2019.1584887.
   PubMedGoogle Scholar
• Espiau Romera A, Cuesta Guardiola T, Benito Vielba M, et al. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer. Int J Gynaecol Obstet. 2020;149(3):265–268. doi:10.1002/ijgo.13140.
   PubMed Web of Science ®Google Scholar
• Han S-S, Lee SH, Kim DH, et al. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. Acta Obstet Gynecol Scand. 2010;89(2):168–174. doi:10.3109/00016340903370114.
   PubMed Web of Science ®Google Scholar
• Taşkın S, Şükür YE, Varlı B, et al. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment. Arch Gynecol Obstet. 2017;296(4):803–809. doi:10.1007/s00404-017-4477-7.
   PubMed Web of Science ®Google Scholar
• Wakayama A, Kudaka W, Matsumoto H, et al. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer. Int J Clin Oncol. 2018;23(3):532–538. doi:10.1007/s10147-017-1227-6.
   PubMed Web of Science ®Google Scholar
• Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109(1):11–18. doi:10.1016/j.ygyno.2008.01.023.
   PubMed Web of Science ®Google Scholar
• Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynecol Obstet. 2018;143:37–50. doi:10.1002/ijgo.12612.
   PubMed Web of Science ®Google Scholar
• Ouldamer L, Bendifallah S, Body G, et al. Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group. Br J Cancer. 2016;115(11):1296–1303. doi:10.1038/bjc.2016.337.
   PubMed Web of Science ®Google Scholar
• Huijgens AN, Mertens HJ. Factors predicting recurrent endometrial cancer. Facts Views Vis Obgyn. 2013;5(3):179–186.
   PubMedGoogle Scholar
• Ouldamer L, Bendifallah S, Body G, Groupe de Recherche FRANCOGYN, et al. Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: an age stratified multicentre study from the FRANCOGYN group. Eur J Surg Oncol. 2018;44(12):1914–1920. doi:10.1016/j.ejso.2018.07.053.
   PubMed Web of Science ®Google Scholar
• Jiang P, Jia M, Hu J, et al. Prognostic value of Ki67 in patients with stage 1-2 endometrial cancer: Validation of the cut-off value of Ki67 as a predictive factor. Onco Targets Ther. 2020;13:10841–10850. doi:10.2147/OTT.S274420.
   PubMed Web of Science ®Google Scholar
• Yang B, Shan B, Xue X, et al. Predicting lymph node metastasis in endometrial cancer using serum CA125 combined with immunohistochemical markers PR and Ki67, and a comparison with other prediction models. PLoS One. 2016;11(5):e0155145. doi:10.1371/journal.pone.0155145.
   PubMed Web of Science ®Google Scholar
• Gulseren V, et al. Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis? Curr Probl Cancer. 100498;2020;44 doi:10.1016/j.currproblcancer.2019.07.003.
   Web of Science ®Google Scholar
• Di Donato V, Iacobelli V, Schiavi MC, et al. Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer. Int J Gynecol Cancer. 2018;28(3):505–513. doi:10.1097/IGC.0000000000001191.
   PubMed Web of Science ®Google Scholar
• Li M, Zhao L, Shen D, et al. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma. Chin Med J (Engl). 2014;127(8):1459–1463.
   PubMed Web of Science ®Google Scholar
• Markova I, Duskova M, Lubusky M, et al. Selected immunohistochemical prognostic factors in endometrial cancer. Int J Gynecol Cancer. 2010;20(4):576–582. doi:10.1111/IGC.0b013e3181d80ac4.
   PubMed Web of Science ®Google Scholar
• Tomica D, Ramić S, Danolić D, et al. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer. J Obstet Gynaecol. 2018;38(1):96–102. doi:10.1080/01443615.2017.1328591.
   PubMedGoogle Scholar
• Jia M, Jiang P, Huang Z, et al. The combined ratio of estrogen, progesterone, Ki-67, and P53 to predict the recurrence of endometrial cancer. J Surg Oncol. 2020;122(8):1808–1814. doi:10.1002/jso.26212.
   PubMed Web of Science ®Google Scholar
• Sari ME, Yalcin I, Sahin H, Meydanli MM, Gungor T. Risk factors for paraaortic lymph node metastasis in endometrial cancer. Int J Clin Oncol. 2017;22(5):937–944. doi:10.1007/s10147-017-1139-5.
   PubMed Web of Science ®Google Scholar
• Bogani G, Dowdy SC, Cliby WA, et al. Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol. 2016;37(1):6–12.
   PubMed Web of Science ®Google Scholar
• Corr BR, Carrubba A, Sheeder J, Cheng G, Guntupalli SR. Histopathology discrepancy of preoperative endometrial sampling and final specimen: How does this influence selective lymph node dissection? Int J Gynecol Cancer. 2017;27(2):297–301. doi:10.1097/IGC.0000000000000866.
   PubMed Web of Science ®Google Scholar
• Di Spiezio Sardo A, De Angelis MC, Della Corte L, et al. Should endometrial biopsy under direct hysteroscopic visualization using the grasp technique become the new gold standard for the preoperative evaluation of the patient with endometrial cancer? Gynecol Oncol. 2020;158(2):347–353. doi:10.1016/j.ygyno.2020.05.012.
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw. 2014;12(2):288–297. doi:10.6004/jnccn.2014.0026.
   PubMed Web of Science ®Google Scholar
• Bogani G, Casarin J, Leone Roberti Maggiore U, et al. Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: Long-term results of a propensity-matched analysis. Gynecol Oncol. 2020;158(1):77–83. doi:10.1016/j.ygyno.2020.04.691.
   PubMed Web of Science ®Google Scholar
• Bogani G, Di Donato V, Papadia A, et al. Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancer. Gynecol Oncol. 2022;166(2):277–283. doi:10.1016/j.ygyno.2022.06.007.
   PubMed Web of Science ®Google Scholar